Home » Topics » Science » New compound

New compound
RSS

Anti-CD3 DARPin T-cell engager is active only in the tumor microenvironment

May 11, 2021

GQ-127 shows in vitro and in vivo antitumor activity in uveal melanoma

May 10, 2021

Discovery and preclinical characterization of novel bifunctional anti-PD-1 x IL-15 proteins

May 7, 2021

Intraocular pressure lowering by soluble guanylate cyclase inhibitor ID-65-CW69 studied in monkeys

May 7, 2021

Boswellic acid derivative inhibits Th17 cell differentiation by targeting eIF2alpha

May 6, 2021

Novel GLUT5 inhibitor molecule to treat fructose-induced diseases

May 6, 2021

Preclinical characterization of novel small molecule inhibitor of CD38, RBN-013209

May 5, 2021

Zenshine compounds targeting E-NPP 1 have antitumor activity

May 5, 2021

KRAS G12C inhibitor BI-1823911 shows in vivo efficacy, to enter clinical study

April 28, 2021

Aurigene details preclinical activity of anticancer compounds AU-18069 and AU-19820

April 27, 2021

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...